R. McMenemin

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

Corinne Faivre‐Finn, M. Snee, Linda Ashcroft et al. · The Lancet Oncology · 2017 · 548 citations · Full text

A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma

N. O’Rourke, Jose Curto Garcia, Claire Lawless et al. · Radiotherapy and Oncology · 2007 · 180 citations

Surgical Oncology, Malignant Pleural Mesothelioma, Radiation Therapy +7

Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy

Prabhakar Rajan, Ian Sudbery, M. Eugenia M. Villasevil et al. · European Urology · 2013 · 159 citations · Full text

Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial

Tim Eisen, Eleni Frangou, Bhavna Oza et al. · Journal of Clinical Oncology · 2020 · 128 citations · Full text

SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer and good performance status

J. Maguire, Iftekhar Khan, R. McMenemin et al. · European Journal of Cancer · 2014 · 127 citations

Radiation Therapy, Good Performance Status, Medicine +6